We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$612M
AUM Growth
+$115M
Cap. Flow
+$88.3M
Cap. Flow %
14.44%
Top 10 Hldgs %
8.98%
Holding
532
New
97
Increased
238
Reduced
88
Closed
80

Top Buys

Rank Stock Value
1
TEO icon
Telecom Argentina
TEO
+$2.03M
2
MEOH icon
Methanex
MEOH
+$1.43M
3
EQM
EQM Midstream Partners, LP
EQM
+$1.32M
4
CGBD icon
Carlyle Secured Lending
CGBD
+$1.31M
5
GEO icon
The GEO Group
GEO
+$1.3M

Top Sells

Rank Stock Value
1
OXSQ icon
Oxford Square Capital
OXSQ
+$2.73M
2
MPLX icon
MPLX
MPLX
+$1.51M
3
MDCO
Medicines Co
MDCO
+$982K
4
GAIN icon
Gladstone Investment Corp
GAIN
+$857K
5
CELG
Celgene Corp
CELG
+$712K

Sector Composition

Rank Sector Weight
1 Financials 20.46%
2 Real Estate 16.88%
3 Energy 14.34%
4 Healthcare 10.85%
5 Materials 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XNCR icon
276
Xencor
XNCR
$1.47B
$379K 0.06%
11,034
+2,969
+37% +$108K
TECX
277
Tectonic Therapeutic
TECX
$582M
$379K 0.06%
1,569
+14
+0.9% +$2.7K
KYNB
278
Kyntra Bio
KYNB
$28.4M
$378K 0.06%
353
+104
+42% +$106K
GERN icon
279
Geron
GERN
$956M
$374K 0.06%
274,658
+105,091
+62% +$152K
EIDX
280
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$372K 0.06%
6,481
-1,566
-19% -$77.5K
CBIO
281
Crescent Biopharma
CBIO
$639M
$366K 0.06%
691
+465
+206% +$252K
UBX
282
DELISTED
Unity Biotechnology
UBX
$355K 0.06%
4,928
+2,034
+70% +$143K
ALEC icon
283
Alector
ALEC
$169M
$351K 0.06%
20,384
+7,858
+63% +$134K
KRYS icon
284
Krystal Biotech
KRYS
$9.97B
$349K 0.06%
6,307
-2,976
-32% -$146K
SRNE
285
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$342K 0.06%
101,216
+21,002
+26% +$50.1K
DRNA
286
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$339K 0.06%
15,371
-1,744
-10% -$35.1K
ALLK
287
DELISTED
Allakos
ALLK
$319K 0.05%
3,350
-2,653
-44% -$233K
GOSS icon
288
Gossamer Bio
GOSS
$72.8M
$254K 0.04%
16,245
+3,772
+30% +$76K
BABA icon
289
Alibaba
BABA
$272B
$141K 0.02%
667
+79
+13% +$14.8K
FLIN icon
290
Franklin FTSE India ETF
FLIN
$2.71B
$127K 0.02%
5,525
-3,584
-39% -$80.8K
AMZN icon
291
Amazon
AMZN
$2.51T
$103K 0.02%
+1,120
New +$99.1K
WVE icon
292
Wave Life Sciences
WVE
$1.14B
$88K 0.01%
10,948
+1,109
+11% +$27.2K
META icon
293
Meta Platforms (Facebook)
META
$1.53T
$83K 0.01%
+404
New +$78.3K
BKNG icon
294
Booking.com
BKNG
$143B
$70K 0.01%
+850
New +$66.7K
UNH icon
295
UnitedHealth
UNH
$379B
$65K 0.01%
+221
New +$57.8K
BMY icon
296
Bristol-Myers Squibb
BMY
$129B
$59K 0.01%
+919
New +$52.6K
MA icon
297
Mastercard
MA
$487B
$55K 0.01%
185
+120
+185% +$33.8K
V icon
298
Visa
V
$688B
$55K 0.01%
+293
New +$52.8K
AMX icon
299
America Movil
AMX
$77.8B
$54K 0.01%
3,400
+822
+32% +$12.9K
ADBE icon
300
Adobe
ADBE
$93.6B
$48K 0.01%
147
+99
+206% +$29.1K
10 11
12
13 14

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Virtus ETF Advisers held 532 positions worth $612M, up 23% from $496M the previous quarter. Its ten largest holdings account for 9% of the portfolio.

Virtus ETF Advisers deployed $88.3M of net new capital in Q4 2019, opening 97 new positions and adding to 238 existing holdings. Its largest new stake was Odonate Therapeutics, Inc. Common Stock: 14,229 shares worth $462K.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 24% a quarter earlier, followed by Real Estate and Energy.

On the sell side, the largest reduction was Oxford Square Capital, an estimated $2.73M trimmed.

  • Virtus ETF Advisers's largest Q4 2019 buy was Odonate Therapeutics, Inc. Common Stock: 14,229 shares worth $462K.
  • Virtus ETF Advisers added most to Telecom Argentina in Q4 2019, an estimated $2.03M increase.
  • Virtus ETF Advisers's biggest Q4 2019 reduction was Oxford Square Capital, cutting an estimated $2.73M.
  • Virtus ETF Advisers fully exited Medicines Co in Q4 2019, selling an estimated $982K.
  • Virtus ETF Advisers's ten largest holdings make up 9% of its $612M portfolio in Q4 2019.
  • Virtus ETF Advisers opened 97 new positions and closed 80 in Q4 2019.
  • Virtus ETF Advisers's portfolio value rose 23% quarter-over-quarter to $612M.

Based on Virtus ETF Advisers's 13F filing for Q4 2019, filed 13 Feb 2020.